DeutschNewstral
Article
POLITICO on 2021-05-19 19:16
J&J vaccine production could restart in U.S. 'within days,' Emergent executive testifies
Related news
- FDA orders J&J contractor Emergent to stop vaccine production during inspectionPOLITICO
Emergent: FDA letting troubled COVID vaccine factory restartdailyherald.com- FDA inspection report casts doubt on J&J vaccine contractor's ability to restart productionPOLITICO
FDA OK's Emergent BioSolutions plant to resume manufacturing J&J's Covid vaccineCNN- Emergent admits to manufacturing issues with J&J vaccinePOLITICO
Emergent BioSolutions ‘hopeful’ to return to vaccine production, plans to submit response to FDA ‘within days’bizjournals.com
J&J vaccine supply has run out; Emergent says it’s working on improvementsArs Technica- MIn response to Emergent CEO, the FDA has over 100 million J&J Covid vaccine doses out there for additional testing after botched picturesmvtelegraph.com
- After ruining 75M J&J doses, Emergent gets FDA clearance for 25M dosesArs Technica
- Emergent BioSolutions calls J&J vaccine manufacturing error at Baltimore facility 'disappointing'bizjournals.com
Johnson & Johnson confirmed vaccine production problems at Emergent plant in BaltimoreSeattle Times- What J&J’s Covid-19 vaccine situation means for Maryland’s Emergent BioSolutionsbizjournals.com
FDA, J&J Near Deal for Covid-19 Vaccine Production at Baltimore Plantwsj.com- Emergent BioSolutions calls J&J vaccine manufacturing error 'disappointing'bizjournals.com
- MEmergent BioSolutions inks coronavirus vaccine manufacturing deal with J&Jmarketwatch.com
- Emergent BioSolutions setbacks cause J&J vaccine supply to dwindlebizjournals.com
FDA allows Emergent factory to resume vaccine worknwaonline.com